CMMB
Chemomab Therapeutics
CMMB
CMMB
15 hedge funds and large institutions have $1.71M invested in Chemomab Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$68.4K | |
| 2 | +$24.5K | |
| 3 | +$15.7K | |
| 4 |
Morgan Stanley
New York
|
+$1.95K |
Top Sellers
| 1 | -$129K | |
| 2 | -$71.5K | |
| 3 | -$24.3K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$12.7K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.38K |